You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 11, 2025

List of Excipients in API hydromorphone hydrochloride


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing hydromorphone hydrochloride

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
SpecGx LLC HYDROMORPHONE HYDROCHLORIDE hydromorphone hydrochloride 0406-3308 ANHYDROUS LACTOSE
SpecGx LLC HYDROMORPHONE HYDROCHLORIDE hydromorphone hydrochloride 0406-3308 BUTYLATED HYDROXYTOLUENE
SpecGx LLC HYDROMORPHONE HYDROCHLORIDE hydromorphone hydrochloride 0406-3308 CELLULOSE ACETATE
SpecGx LLC HYDROMORPHONE HYDROCHLORIDE hydromorphone hydrochloride 0406-3308 FERRIC OXIDE RED
SpecGx LLC HYDROMORPHONE HYDROCHLORIDE hydromorphone hydrochloride 0406-3308 FERROSOFERRIC OXIDE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing hydromorphone hydrochloride

Company Ingredient NDC Excipient
Hikma Pharmaceuticals USA Inc hydromorphone hydrochloride 0054-0264 ANHYDROUS LACTOSE
Hikma Pharmaceuticals USA Inc hydromorphone hydrochloride 0054-0264 MAGNESIUM STEARATE
SpecGx LLC hydromorphone hydrochloride 0406-3243 CELLULOSE, MICROCRYSTALLINE
SpecGx LLC hydromorphone hydrochloride 0406-3243 LACTOSE MONOHYDRATE
SpecGx LLC hydromorphone hydrochloride 0406-3243 MAGNESIUM STEARATE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for hydromorphone hydrochloride

Excipient focus: ACETONE

Excipient focus: AMMONIO METHACRYLATE COPOLYMER TYPE A

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: BUTYLATED HYDROXYTOLUENE

Excipient focus: CELLULOSE ACETATE

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CITRIC ACID MONOHYDRATE

Excipient focus: D&C RED NO. 30

Excipient focus: D&C YELLOW NO. 10

Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE

Excipient focus: EDETATE DISODIUM

Excipient focus: ETHYLCELLULOSE

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 6 ALUMINUM LAKE

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GLYCERIN

Excipient focus: HYDROCHLORIC ACID

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2208

Excipient focus: HYPROMELLOSE 2910

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LACTIC ACID

Excipient focus: LACTOSE

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: LACTOSE, ANHYDROUS

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MANNITOL

Excipient focus: METHYLPARABEN

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 3350

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 7000000

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: POLYETHYLENE OXIDE 200000

Excipient focus: POLYSORBATE 80

Excipient focus: POVIDONE

Excipient focus: POVIDONE K30

Excipient focus: POVIDONES

Excipient focus: PROPYLENE GLYCOL

Excipient focus: PROPYLPARABEN

Excipient focus: RASPBERRY

Excipient focus: SACCHARIN SODIUM ANHYDROUS

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM CHLORIDE

Excipient focus: SODIUM CITRATE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM LACTATE

Excipient focus: SODIUM METABISULFITE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: SORBITOL

Excipient focus: STEARIC ACID

Excipient focus: SUCROSE

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: TRIETHYL CITRATE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links